Showing results (1-10 of 61) with videos related to
Sort By:
Pageof 7
Expert Opinion on Investigational Drugs|September 13, 2002
Novel therapeutics for the treatment of graft-versus-host diseaseDavid A JacobsohnExpert Opinion on Emerging Drugs|December 10, 2003
Emerging therapies for graft-versus-host diseaseDavid A JacobsohnBritish Journal of Haematology|June 18, 2010
Optimal management of chronic graft-versus-host disease in childrenDavid A JacobsohnCurrent Pharmaceutical Design|April 14, 2004
Anti-cytokine therapy for the treatment of graft-versus-host diseaseDavid A Jacobsohn, Georgia B VogelsangOrphanet Journal of Rare Diseases|September 6, 2007
Acute graft versus host diseaseDavid A Jacobsohn, Georgia B VogelsangDrugs|April 4, 2002
Novel pharmacotherapeutic approaches to prevention and treatment of GVHDDavid A Jacobsohn, Georgia B VogelsangCytotherapy|July 17, 2016
Cellular therapy for sickle cell diseaseAllistair Abraham, David A Jacobsohn, Catherine M BollardLancet (London, England)|July 13, 2004
Reduced intensity haemopoietic stem-cell transplantation for treatment of non-malignant diseases in childrenDavid A Jacobsohn, Reggie Duerst, William Tse, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Gastrointestinal toxicity from the preparative regimen is associated with an increased risk of graft-versus-host diseaseJenna Goldberg, David A Jacobsohn, Marianna L Zahurak, et al.Pageof 7